3
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Joint consensus statement on the vaccination of adult and paediatric haematopoietic stem cell transplant recipients: Prepared on behalf of the British society of blood and marrow transplantation and cellular therapy (BSBMTCT), the Children's cancer and Leukaemia Group (CCLG), and British Infection Association (BIA).

      Read this article at

      ScienceOpenPublisherPubMed
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Haematopoietic stem cell transplant (HSCT) recipients have deficiencies in their adaptive immunity against vaccine preventable diseases. National and International guidance recommends that HSCT recipients are considered 'never vaccinated' and offered a comprehensive course of revaccination. This position statement aims to draw upon the current evidence base and existing guidelines, and align this with national vaccine availability and licensing considerations in order to recommend a pragmatic and standardised re-vaccination schedule for adult and paediatric HSCT recipients in the UK.

          Related collections

          Author and article information

          Journal
          J Infect
          The Journal of infection
          Elsevier BV
          1532-2742
          0163-4453
          Jan 2023
          : 86
          : 1
          Affiliations
          [1 ] British Society of Blood and Marrow Transplantation and Cellular Therapy, UK.
          [2 ] Paediatric Department, Croydon Health Services NHS Trust, Croydon, UK.
          [3 ] University of Newcastle upon Tyne, Newcastle upon Tyne, UK.
          [4 ] Department of Clinical Haematology, University of Manchester, Manchester, UK.
          [5 ] Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, UK.
          [6 ] Oxford University Hospitals NHS Foundation Trust, Oxford, UK.
          [7 ] St. James' Hospital, Leeds, UK.
          [8 ] Vaccine Institute, Institute of Infection and Immunity, St. George's, University of London, London, UK.
          [9 ] NHS Greater Glasgow and Clyde, Glasgow, UK.
          [10 ] Wessex Blood and Marrow Transplant and Cellular Therapy Program, Department of Haematology, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
          [11 ] Department of Haematology, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK; Department of Oncology and Metabolism, Medical School, The University of Sheffield, Sheffield, UK.
          [12 ] Department of Infection, Immunity and Cardiovascular Disease, Medical School, The University of Sheffield, Sheffield, UK. Electronic address: t.desilva@sheffield.ac.uk.
          Article
          S0163-4453(22)00646-6
          10.1016/j.jinf.2022.11.005
          36400155
          96cab32b-9e6d-48bc-afca-c505d3e00252
          History

          Haematopoietic stem cell transplant,Immunisation,Vaccination

          Comments

          Comment on this article